Yahoo Malaysia Web Search

Search results

  1. 2 days ago · View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns. As of July 3, 2024. The Bloomberg Billionaires Index is a daily ranking ...

    • Klaus-Michael Kuehne

      The majority of Klaus-Michael Kuehne's wealth is derived...

    • Michael Dell

      He was soon sidetracked selling computers. Armed with $1,000...

    • Alwaleed Bin Talal

      Alwaleed's most valuable asset is a 78% stake in publicly...

    • Rob Walton

      Rob is the oldest son of Sam Walton, who opened his first...

    • Alice Walton

      The only daughter of Walmart founder Sam Walton, Alice...

    • Alain Wertheimer

      Alain Ernest Wertheimer was born to racehorse owner Jacques...

    • Jan Koum

      The majority of Koum's fortune is derived from the proceeds...

    • Ken Griffin

      A June 2019 S&P Global Ratings report stated that he held an...

  2. www.forbes.com › profile › patrick-soon-shiongPatrick Soon-Shiong - Forbes

    3 days ago · Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer. He sold his drug companies Abraxis in 2010 and...

  3. 1 day ago · Long before construction broke ground, plans for the arena were negotiated between elected city officials and real estate developers Edward P. Roski of Majestic Realty and Philip Anschutz.

  4. www.forbes.com › profile › philip-anschutzPhilip Anschutz - Forbes

    3 days ago · Over five decades, Philip Anschutz has built fortunes in oil, railroads, telecom, real estate and entertainment. He is the majority owner of the NHL's Los Angeles Kings, with a stake in the...

  5. Jul 2, 2024 · Borrowing from basketball terminology, ImmunityBio’s chairman and chief scientific and medical officer, Patrick Soon-Shiong, said Anktiva’s mechanism is a ‘triangle offence’ that “begins the...

  6. Jun 20, 2024 · “We are grateful to be able to offer this first-in-class immunotherapy to qualified bladder cancer patients less than two months after the therapeutic was approved by the FDA,” said Patrick Soon-Shiong, M.D., Executive Chairman and Global Chief Scientific and Medical Officer at ImmunityBio. “The interest in this next era of immunotherapy ...

  7. 4 days ago · Soon-Shiong became a billionaire after selling two drug companies: APP Pharmaceuticals and Abraxis BioScience. He sold APP to Fresenius Medical Care for $4.6 billion in 2008, and Abraxis to ...